Long-Term Clinical Benefit in EGFR-Mutant Lung Adenocarcinoma With Local Squamous Cell Carcinoma Transformation After EGFR TKI Resistance: A Case Report

The histological transformation from adenocarcinoma (ADC) to squamous cell carcinoma (SCC) is rare but recurrently occurs post TKI treatment in EGFR-mutated non-small cell lung cancer patients with a very limited number of clinical cases published. The outcome of patients after SCC onset is poor as...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Junru, Ma, Yutong, Ou, Qiuxiang, Yan, Junrong, Ye, Bin, Li, Yuping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178119/
https://www.ncbi.nlm.nih.gov/pubmed/35692748
http://dx.doi.org/10.3389/fonc.2022.883367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178119/
https://www.ncbi.nlm.nih.gov/pubmed/35692748
http://dx.doi.org/10.3389/fonc.2022.883367

Ejemplares similares